1-3 of 3
José Bartelt-Hofer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Patients with Hemophilia and Their Caregivers Prefer Treatment Attributes That Enable a More Active Lifestyle with Lower Risk of Inhibitor Development

Viridiana Cano, Carol Mansfield, Anna Pierce, Colton Leach, Jane Cavanaugh Smith, Pronabesh DasMahapatra, José Bartelt-Hofer
Journal: Blood
Blood (2022) 140 (Supplement 1): 7991–7992.
https://doi.org/10.1182/blood-2022-168405
Published: 2022
Journal Articles

Fitusiran Reaches People's with Hemophilia and Their Caregivers’ Treatment Expectations: Qualitative Semi-Structured Interviews of Participants of ATLAS-OLE Trial (Interim analysis)

Alok Srivastava, Savita Rangarajan, Cecil Ross, Christina Slota, Dana DiBenedetti, Viridiana Cano, Shauna Andersson, Pronabesh Dasmahapatra, José Bartelt-Hofer, Marion Afonso
Journal: Blood
Blood (2022) 140 (Supplement 1): 7989–7990.
https://doi.org/10.1182/blood-2022-166895
Published: 2022
Journal Articles

Sustained Improvement in Health-Related Quality of Life in Patients with Hemophilia A with or without Inhibitors Treated with Fitusiran Prophylaxis

Viridiana Cano, José Bartelt-Hofer, Wenruo Hu, Shauna R. Andersson, Pronabesh Dasmahapatra, Sylvia Von Mackensen
Journal: Blood
Blood (2021) 138 (Supplement 1): 3197.
https://doi.org/10.1182/blood-2021-147286
Published: 2021